• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

密苏里州的芬太尼问题:与中国的关联。

Missouri's Fentanyl Problem: The China Connection.

作者信息

Stoecker William V, Bosworth K Taylor, Rottnek Fred

机构信息

MSMA member since 1984, practices at S&A Technologies and The Dermatology Center, Rolla, Missouri, and the Department of Dermatology, University of Missouri-Columbia Health Sciences Center, Columbia, Missouri.

Departments of Biological Sciences and Psychological Science, Missouri University of Science and Technology, Rolla, Missouri.

出版信息

Mo Med. 2020 Jul-Aug;117(4):362-369.

PMID:32848274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7431056/
Abstract

Recently, Missouri has followed an overall upward trend in opioid overdose deaths. In 2018, Missouri was the state with the largest absolute and percentage increase in opioid-related overdose fatality rates per capita over the previous year (18.3% and 3.1/100,000). This increase occurred despite an overall decrease in U.S. opioid-related death rates in the same period. This report identifies illicitly manufactured fentanyl (IMF) (and analogues) as the drug most responsible for this rise in opioid deaths in Missouri, with stimulant overdoses (primarily from methamphetamine) in second place. Within Missouri, we find the areas where opioid deaths are highest: St. Louis and the city's fringe areas, following the national trend for high rates in fringe areas. Based on reports from CDC Wonder data, county medical examiners, law enforcement agencies, and drug addiction prevention agencies, we conclude that IMF and related synthetic opioids arriving from China are primarily responsible for fatal narcotic overdoses in Missouri. Despite the COVID-19 disruption of fentanyl manufacturing and distribution centers in and around Wuhan, China early in the pandemic, preliminary 2020 data from medical examiners' offices show an upswing in opioid deaths, an indicator that Chinese fentanyl producers have restored the supply chain.

摘要

最近,密苏里州的阿片类药物过量死亡人数呈总体上升趋势。2018年,密苏里州是人均阿片类药物相关过量死亡率较上一年绝对增幅和百分比增幅最大的州(分别为18.3%和3.1/10万)。尽管同期美国阿片类药物相关死亡率总体下降,但这一增长仍出现了。本报告确定非法制造的芬太尼(IMF)(及其类似物)是密苏里州阿片类药物死亡人数上升的最主要原因,兴奋剂过量(主要来自甲基苯丙胺)位居第二。在密苏里州内,我们发现阿片类药物死亡人数最多的地区:圣路易斯及其周边地区,这与全国边缘地区高死亡率的趋势一致。根据美国疾病控制与预防中心(CDC)Wonder数据、县法医办公室、执法机构和药物成瘾预防机构的报告,我们得出结论,从中国运来的IMF及相关合成阿片类药物是密苏里州致命麻醉品过量的主要原因。尽管在疫情早期,新冠疫情对中国武汉及其周边地区的芬太尼制造和分销中心造成了干扰,但法医办公室2020年的初步数据显示阿片类药物死亡人数有所上升,这表明中国芬太尼生产商已恢复了供应链。

相似文献

1
Missouri's Fentanyl Problem: The China Connection.密苏里州的芬太尼问题:与中国的关联。
Mo Med. 2020 Jul-Aug;117(4):362-369.
2
Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.芬太尼执法上报与涉及合成阿片类药物的过量死亡人数增加-27 个州,2013-2014 年。
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):837-43. doi: 10.15585/mmwr.mm6533a2.
3
Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.在一个非法药物供应中芬太尼日益增多的城市,非医疗实践中用于逆转阿片类药物过量的纳洛酮用量。
Subst Abus. 2019;40(1):52-55. doi: 10.1080/08897077.2018.1449053. Epub 2018 Jun 25.
4
Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids.进入戒毒治疗人群中自我报告的芬太尼使用量增加:对非法制造阿片类药物进行系统监测的必要性。
Drug Alcohol Depend. 2017 Aug 1;177:101-103. doi: 10.1016/j.drugalcdep.2017.04.004. Epub 2017 May 30.
5
The Rapid Escalation of Fentanyl in Illicit Drug Evidence in Allegheny County, Pennsylvania, 2010-2016.2010-2016 年宾夕法尼亚州阿勒格尼县非法药物证据中芬太尼的迅速升级。
Public Health Rep. 2018 Mar/Apr;133(2):142-146. doi: 10.1177/0033354917753119. Epub 2018 Feb 1.
6
Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.药物和阿片类药物过量死亡人数增加 - 美国,2000-2014 年。
MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
7
Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S.?欧洲是否面临与美国类似的新兴阿片类药物危机?
Ther Drug Monit. 2021 Feb 1;43(1):42-51. doi: 10.1097/FTD.0000000000000789.
8
Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality.疫情演变:了解美国的阿片类药物流行情况以及 COVID-19 大流行对阿片类药物相关死亡率的影响。
PLoS One. 2024 Jul 9;19(7):e0306395. doi: 10.1371/journal.pone.0306395. eCollection 2024.
9
Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019.2019 年美国报告非法制造的芬太尼或海洛因使用或处方阿片类药物滥用的成年人特征。
Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109160. doi: 10.1016/j.drugalcdep.2021.109160. Epub 2021 Oct 30.
10
Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.重新构建阿片类药物危机的预防策略:聚焦处方阿片类药物、芬太尼和海洛因流行。
Pain Physician. 2018 Jul;21(4):309-326.

引用本文的文献

1
Examining Increasing Racial Inequities in Opioid Overdose Deaths: a Spatiotemporal Analysis of Black and White Decedents in St. Louis, Missouri, 2011-2021.探讨阿片类药物过量死亡中日益加剧的种族不平等现象:2011-2021 年密苏里州圣路易斯市黑人和白人死者的时空分析。
J Urban Health. 2023 Jun;100(3):436-446. doi: 10.1007/s11524-023-00736-9. Epub 2023 May 23.
2
Part II: Missouri's Fentanyl Poisonings Rise to Record Levels.第二部分:密苏里州的芬太尼中毒事件上升至创纪录水平。
Mo Med. 2023 Jan-Feb;120(1):10-14.
3
Identifying drivers of increasing opioid overdose deaths among black individuals: a qualitative model drawing on experience of peers and community health workers.确定导致黑人阿片类药物过量死亡人数增加的因素:基于同伴和社区卫生工作者经验的定性模型。
Harm Reduct J. 2023 Jan 13;20(1):5. doi: 10.1186/s12954-023-00734-9.
4
Part I: Missouri's Fentanyl Poisonings Rise to Record Levels.第一部分:密苏里州的芬太尼中毒事件上升至创纪录水平。
Mo Med. 2022 Nov-Dec;119(6):489-493.
5
Leading change during the convergence of an epidemic and a pandemic.在流行病和大流行病交汇期间引领变革。
J Adv Nurs. 2020 Dec;76(12):3215-3217. doi: 10.1111/jan.14567. Epub 2020 Sep 30.

本文引用的文献

1
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.药物和阿片类药物相关过量死亡 - 美国,2017-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
2
Human deaths from drug overdoses with carfentanyl involvement-new rising problem in forensic medicine: A STROBE-compliant retrospective study.涉及卡芬太尼的药物过量导致的人类死亡——法医学中的新出现问题:一项符合STROBE标准的回顾性研究。
Medicine (Baltimore). 2018 Nov;97(48):e13449. doi: 10.1097/MD.0000000000013449.
3
Analysis of Fentanyl and 18 Novel Fentanyl Analogs and Metabolites by LC-MS-MS, and report of Fatalities Associated with Methoxyacetylfentanyl and Cyclopropylfentanyl.通过液相色谱-串联质谱法分析芬太尼及18种新型芬太尼类似物和代谢物,并报告与甲氧基乙酰芬太尼和环丙基芬太尼相关的死亡案例。
J Anal Toxicol. 2018 Nov 1;42(9):592-604. doi: 10.1093/jat/bky035.
4
Life (and death) in Pink: The dangerous rise of synthetic opioids in the new psychoactive substances panorama.粉色地带的生与死:新精神活性物质图景中合成阿片类药物的危险崛起。
Eur Neuropsychopharmacol. 2018 Jan;28(1):225-226. doi: 10.1016/j.euroneuro.2017.12.008. Epub 2017 Dec 15.
5
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update.非法芬太尼及其类似物导致的急性中毒和死亡:最新情况
Ther Drug Monit. 2018 Feb;40(1):38-51. doi: 10.1097/FTD.0000000000000465.
6
Fentanyl in the US heroin supply: A rapidly changing risk environment.美国海洛因供应中的芬太尼:迅速变化的风险环境。
Int J Drug Policy. 2017 Aug;46:107-111. doi: 10.1016/j.drugpo.2017.06.010. Epub 2017 Jul 20.
7
An Expanding World of Novel Psychoactive Substances: Opioids.新型精神活性物质的不断扩展的世界:阿片类药物。
Front Psychiatry. 2017 Jun 30;8:110. doi: 10.3389/fpsyt.2017.00110. eCollection 2017.
8
Misuse of Novel Synthetic Opioids: A Deadly New Trend.新型合成阿片类药物的滥用:一种致命的新趋势。
J Addict Med. 2017 Jul/Aug;11(4):256-265. doi: 10.1097/ADM.0000000000000324.
9
The Textures of Heroin: User Perspectives on "Black Tar" and Powder Heroin in Two U.S. Cities.海洛因的质地:美国两个城市的使用者对“黑焦油”海洛因和粉末状海洛因的看法
J Psychoactive Drugs. 2016 Sep-Oct;48(4):270-8. doi: 10.1080/02791072.2016.1207826. Epub 2016 Jul 20.
10
N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin.N-4-取代的1-(2-芳基乙基)-4-哌啶基-N-苯基丙酰胺,一类新型的极具效力且安全边际异常高的镇痛药。
Arzneimittelforschung. 1976;26(8):1548-51.